A61P 37 - Drugs for immunological or allergic disorders

Patents for A61P 37 - Drugs for immunological or allergic disorders (117,141)
11/2006
11/15/2006	EP0969836B1 Lactose-free, non-hygroscopic and anhydrous pharmaceutical compositions of descarboethoxyloratadine
11/15/2006	EP0968206B1 N-heterocyclic derivatives as nos inhibitors
11/15/2006	CN1863912A A fungal immuromodulatory protein produced by microorganisme and uses there of
11/15/2006	CN1863906A Tolerizing allografts of pluripotent stem cells
11/15/2006	CN1863803A 嘧啶衍生物 Pyrimidine derivatives
11/15/2006	CN1863800A Novel compounds that modulate PPAR type receptors, and use thereof in cosmetic or pharmaceutical compositions
11/15/2006	CN1863555A Compositions and methods for manipulating levels antigen-specific antibodies in a mammal
11/15/2006	CN1863509A Pharmaceutical multiparticulate composition comprising mycophenolic acid or mycophenolate sodium and combination with rapamycin
11/15/2006	CN1861108A Composition able to improve immunity
11/15/2006	CN1861079A Compounding prepn. contg. cefteram pivoxil and pidotimod
11/15/2006	CN1861077A Beta-amino heterocyclic dipeptidyl peptidase inhibitors for the treatment or prevention of diabetes
11/15/2006	CN1861071A Medicine and/or health-care products prepd. by using malic polyphenols to regulate immunity
11/15/2006	CN1861045A Coenzyme Q10 venoclysis injection
11/15/2006	CN1284859C Membrane virus host range mutations and their uses as vaccine substrates
11/15/2006	CN1284854C Mosaic type DNA vaccine in use for preventing tuberculosis and immunological therapy
11/15/2006	CN1284798C Poly thymosin-alpha 1, its composition, its preparation method and application
11/15/2006	CN1284783C Substituted nitrogen contg. heterocycles as inhibitors of P38 progein kinase
11/15/2006	CN1284771C TNF－α生成抑制剂 TNF-α production inhibitor
11/15/2006	CN1284602C Ox colostrum active immune globulin micro capsule and its preparation method
11/15/2006	CN1284593C Medicine for treating anaphylactoid purpura
11/15/2006	CN1284554C Medicine for treating acute urticaria
11/15/2006	CN1284543C Pharmaceutical preparation containing northeast cryrtominetin medicinal preparation and its new use
11/15/2006	CN1284542C Strengthened ganoderma lucidum for possible immunoprophylaxis and immunotherapy of cancers and related diseases as well as its preparing method
11/14/2006	US7135571 Processes for preparing anhydrous and hydrate forms of antihistaminic piperidine derivatives, polymorphs and pseudomorphs thereof
11/14/2006	US7135568 Substituted pyrazolopyrimidines and thiazolopyrimidines
11/14/2006	US7135552 Useful as a candidate for a vaccine against ticks, particularly Ornithodoros moubata
11/14/2006	US7135491 5-Aryltetrazole compounds and uses thereof
11/14/2006	US7135473 Cyclic diamine compound with condensed-ring groups
11/14/2006	US7135471 Aryl oximes
11/14/2006	US7135464 Method of administering decitabine
11/14/2006	US7135320 Adaptor protein FRS2 and related products and methods
11/14/2006	US7135286 Pharmaceutical and diagnostic business systems and methods
11/14/2006	US7135279 4-alpha glucotransferases; enzymes inhibitors; enantimorphs; adrenergic blocking agents; proteases; superoxide dismutases; carbonic anhydrases
11/14/2006	US7135177 Immunoliposomes that optimize internalization into target cells
11/14/2006	CA2342271C Gem substituted hydroxamic acids
11/14/2006	CA2340320C Use of an angiogenic factor for the treatment of microascular angiopathies
11/14/2006	CA2294783C Pharmaceutical compositions for oral administration, comprising an active substance and a cyclodextrin
11/14/2006	CA2244363C Synthetic derivatives of rapamycin as multimerizing agents for chimeric proteins with immunophilin-derived domains
11/14/2006	CA2171836C Crystalline anhydrous mycophenolate mofetil and intravenous formulation thereof
11/12/2006	CA2606334A1 Methods of using phhla2 to co-stimulate t-cells
11/09/2006	WO2006119154A1 Use of pyrimidylamimobenzamide derivatives for the treatment of systematic mastocytosis
11/09/2006	WO2006118328A1 Degranulation inhibitor
11/09/2006	WO2006118256A1 2-aminoquinazoline derivatives
11/09/2006	WO2006118131A1 Peptide having anti-anxiety effect and method for screening thereof
11/09/2006	WO2006117885A1 External preparation for skin
11/09/2006	WO2006117400A2 Use of low doses of oligonucleotides antisense to tgf-beta, vegf, interleukin-10, c-jun, c-fos or prostaglandin e2 genes in the treatment of tumors
11/09/2006	WO2006116948A1 Interleukin-6 polyethylene glycol conjugate and its preparing method and use
11/09/2006	WO2006073311A3 Treatment of ibd
11/09/2006	US20060252934 For treatment of asthma, allergies, inflammation and anxiety; antihistamines; sedatives; tranquilizing agents
11/09/2006	US20060252839 Cyclopenteneones for antiischemic agents, antiinflammatory agents and aging resistance
11/09/2006	US20060252810 e.g. 5-(4-Fluorophenyl)-4-(4-pyridinyl)imidazole-2-thio-3-propyl-N-phthalimide; immunomodulating and cytokine-release-inhibiting action; antiinflammatory agent
11/09/2006	US20060252799 Benzo (F) insoindol derivatives and their use as EP4 receptor ligands
11/09/2006	US20060252797 Receptor regulator
11/09/2006	US20060252792 Immunology for viral diseases and biosynthesis of cytokines of anticancer drugs for tumors
11/09/2006	US20060252790 e.g. 5-{5-[(2,4-dimethyl-1,3-thiazol-5-yl)methyl]-1,3,4-oxadiazol-2-yl}-1-ethyl-N-(tetrahydro-2H-pyran-4-yl)-1H-pyrazolo[3,4-b]pyridin-4-amine; antiinflammatory agent, antiallergen; cognitive impairment; asthma, arthritis
11/09/2006	US20060252718 Sphingolipids polyalkylamine conjugates for use in transfection
11/09/2006	US20060252717 Sphingoid polyalkylamine conjugates for vaccination
11/09/2006	US20060252716 Method for reversing the immunosuppressive effects of the melanoma inhibitory activity "mia"
11/09/2006	US20060252674 Methods for pretreating a subject with extracorporeal photopheresis
11/09/2006	US20060251671 Haemophilus influenza outer membrane protein and use thereof in vaccination
11/09/2006	US20060251660 Antibodies to human IL-1beta
11/09/2006	US20060251653 Methods for treating interleukin-6 related diseases
11/09/2006	US20060251651 Antagonist and agonist which bind to a strong binding site of chemokine receptor
11/09/2006	US20060251635 Lactobacillus rhamnosus polynucleotides, polypeptides and methods for using them
11/09/2006	US20060251623 Packaged virus-like particles
11/09/2006	US20060251588 Delivery of erectile dysfunction drugs through an inhalation route
11/09/2006	US20060251587 Delivery of analgesics through an inhalation route
11/09/2006	US20060251578 Therapeutic and diagnostic compounds, compositions, and methods
11/09/2006	CA2606716A1 Use of pyrimidylaminobenzamide derivatives for the treatment of systematic mastocytosis
11/09/2006	CA2606162A1 Peptide having antianxiety activity and screening method therefor
11/09/2006	CA2591586A1 Use of low doses of oligonucleotides antisense to tgf-beta, vegf, interleukin-10, c-jun, c-fos or prostaglandin e2 genes in the treatment of tumors
11/08/2006	EP1719780A2 Mammalian cytokine-like polypeptide-10
11/08/2006	EP1719757A1 Bicyclo derivative
11/08/2006	EP1719516A1 A pharmaceutical composition used for treating recurrent spontaneous abortion and method thereof
11/08/2006	EP1719511A2 N-[4-(4-amino-2-ethyl-1H-imidazo[4,5-c]quinolin-1-yl)butyl]methanesulfonamide, a pharmaceutical composition comprising the same and use thereof
11/08/2006	EP1719507A1 Beta-2 adrenoceptor agonists for treating connective tissue diseases of the skin
11/08/2006	EP1719506A1 Gene expression controlling agent
11/08/2006	EP1718762A1 Antisense oligonucleotide modulation of stat3 expression
11/08/2006	EP1718628A1 Cinnamic amides, process for their preparation, and pharmaceutical compositions containing them
11/08/2006	EP1718615A1 Novel quinoline-carbaxamides as jack3 kinase modulators
11/08/2006	EP1718332A1 Method for inhibiting the transendothelial migration of cells such as leukocytes or tumor cells by a cd-81 binding subsance and uses thereof
11/08/2006	EP1718307A2 Immunosuppressant compounds and compositions
11/08/2006	EP1718152A2 Aminocyclopentyl pyridopyrazinone modulators of chemokine receptor activity
11/08/2006	EP1539742B1 Indole derivatives useful as histamine h3 antagonists
11/08/2006	EP1337269B1 Association of calpain inhibitors and reactive oxygen species trapping agents
11/08/2006	EP1242438B1 Cytotoxic agents comprising modified doxorubicins and daunorubicins and their therapeutic use
11/08/2006	EP1227791B1 Use of aromatic polycyclic compounds as activators of ppars-type receptors in a cosmetic or pharmaceutical composition
11/08/2006	EP1203587A4 A medicament and method for the production thereof
11/08/2006	EP1021190B1 Amid derivatives as growth hormone release promotors
11/08/2006	EP0993437B1 2-(4-bromo or 4-iodo phenylamino) benzoic acid derivatives and their use as mek inhibitors
11/08/2006	CN1860228A Staple type oligonucleotide and drug comprising the same
11/08/2006	CN1860113A Nicotinamide derivatives useful as PDE4 inhibitors
11/08/2006	CN1859921A Method of processing ginseng for medicinal use and composition
11/08/2006	CN1859910A Solid dispersions comprising tacrolimus
11/08/2006	CN1859909A Solid dispersions comprising tacrolimus
11/08/2006	CN1858068A Method for preparing pollen pini polyose, pollen pipe polyose and its use in medicine
11/08/2006	CN1857637A Health Luling vinegar and its preparing process
11/08/2006	CN1857599A Medicine for lowering blood sugar, blood fat and blood pressure, raising blood flow rate and raising immunity and its preparing method
11/08/2006	CN1857598A Allergical rhinitis treating Chinese medicine
11/08/2006	CN1857590A Medicine for mediating blood cell to raise immunity

1 ... 475 476 477 478 479 480 481 482 483 484 485 486 487 488 489 490 491 492 493 494 495 ... 1172